ZA894754B - 19-substituted progresterone derivatives useful as 19-hydroxylase inhibitors - Google Patents

19-substituted progresterone derivatives useful as 19-hydroxylase inhibitors

Info

Publication number
ZA894754B
ZA894754B ZA894754A ZA894754A ZA894754B ZA 894754 B ZA894754 B ZA 894754B ZA 894754 A ZA894754 A ZA 894754A ZA 894754 A ZA894754 A ZA 894754A ZA 894754 B ZA894754 B ZA 894754B
Authority
ZA
South Africa
Prior art keywords
substituted
progresterone
hydroxylase inhibitors
derivatives useful
compounds
Prior art date
Application number
ZA894754A
Other languages
English (en)
Inventor
Gene Warwick Holbert
Warwick Holbert Gene
John O'neal Johnston
O'neal Johnston John
Original Assignee
Merrell Dow Pharma
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merrell Dow Pharma filed Critical Merrell Dow Pharma
Publication of ZA894754B publication Critical patent/ZA894754B/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J5/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J41/00—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring
    • C07J41/0033—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring not covered by C07J41/0005
    • C07J41/005—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring not covered by C07J41/0005 the 17-beta position being substituted by an uninterrupted chain of only two carbon atoms, e.g. pregnane derivatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J21/00—Normal steroids containing carbon, hydrogen, halogen or oxygen having an oxygen-containing hetero ring spiro-condensed with the cyclopenta(a)hydrophenanthrene skeleton
    • C07J21/005—Ketals
    • C07J21/006—Ketals at position 3
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J31/00—Normal steroids containing one or more sulfur atoms not belonging to a hetero ring
    • C07J31/006—Normal steroids containing one or more sulfur atoms not belonging to a hetero ring not covered by C07J31/003
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J5/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond
    • C07J5/0007—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond not substituted in position 17 alfa
    • C07J5/0015—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond not substituted in position 17 alfa not substituted in position 16
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J51/00—Normal steroids with unmodified cyclopenta(a)hydrophenanthrene skeleton not provided for in groups C07J1/00 - C07J43/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J7/00—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms
    • C07J7/0005—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms not substituted in position 21
    • C07J7/001—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms not substituted in position 21 substituted in position 20 by a keto group
    • C07J7/0015—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms not substituted in position 21 substituted in position 20 by a keto group not substituted in position 17 alfa
    • C07J7/002—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms not substituted in position 21 substituted in position 20 by a keto group not substituted in position 17 alfa not substituted in position 16
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J7/00—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms
    • C07J7/0005—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms not substituted in position 21
    • C07J7/0065—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms not substituted in position 21 substituted in position 20 by an OH group free esterified or etherified
    • C07J7/007—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms not substituted in position 21 substituted in position 20 by an OH group free esterified or etherified not substituted in position 17 alfa
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J71/00—Steroids in which the cyclopenta(a)hydrophenanthrene skeleton is condensed with a heterocyclic ring
    • C07J71/0005—Oxygen-containing hetero ring
    • C07J71/001—Oxiranes

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Steroid Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
ZA894754A 1988-06-28 1989-06-22 19-substituted progresterone derivatives useful as 19-hydroxylase inhibitors ZA894754B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US07/212,409 US4910191A (en) 1988-06-28 1988-06-28 19-substituted progesterone derivatives useful as 19-hydroxylase inhibitors

Publications (1)

Publication Number Publication Date
ZA894754B true ZA894754B (en) 1990-05-30

Family

ID=22790892

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA894754A ZA894754B (en) 1988-06-28 1989-06-22 19-substituted progresterone derivatives useful as 19-hydroxylase inhibitors

Country Status (20)

Country Link
US (1) US4910191A (es)
EP (1) EP0348910B1 (es)
JP (1) JP2729320B2 (es)
KR (1) KR0160280B1 (es)
CN (1) CN1033032C (es)
AT (1) ATE122681T1 (es)
AU (1) AU610473B2 (es)
CA (1) CA1321578C (es)
DE (1) DE68922660T2 (es)
DK (1) DK167534B1 (es)
ES (1) ES2075014T3 (es)
FI (1) FI92706C (es)
HU (1) HU204066B (es)
IE (1) IE66338B1 (es)
IL (1) IL90727A (es)
NO (1) NO174511B (es)
NZ (1) NZ229696A (es)
PH (1) PH25714A (es)
PT (1) PT90988B (es)
ZA (1) ZA894754B (es)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE4433374A1 (de) * 1994-09-20 1996-03-21 Hoechst Ag 17-Desoxi-corticosteroid-21-/O/-Carbonsäure- ester, Verfahren zu deren Herstellung und diese enthaltende Arzneimittel
US7053228B2 (en) 2000-09-18 2006-05-30 Applied Research Systems Ars Holding N.V. Sulfur analogues of 21-hydroxy-6,19-oxidoprogesterone (21OH-6OP) for treating excess of glucocorticoids
DE102006018888A1 (de) * 2006-04-18 2007-10-25 Bayer Schering Pharma Ag Verfahren zur Herstellung von 4-[17beta-Methoxy-17alpha-methoxymethyl-3-oxoestra-4,9-dien-11beta-yl]benzaldehyd-(E)-oxims (Asoprisnil)
ES2524345T3 (es) 2007-04-04 2014-12-05 Sigmoid Pharma Limited Composición farmacéutica oral
EP2432455B1 (en) 2009-05-18 2014-11-12 Sigmoid Pharma Limited Composition comprising oil drops
GB201020032D0 (en) 2010-11-25 2011-01-12 Sigmoid Pharma Ltd Composition
CN102268058B (zh) * 2011-05-24 2012-10-10 湖南诺凯生物医药有限公司 制备17α-羟基孕酮或其类似物的方法
GB201212010D0 (en) 2012-07-05 2012-08-22 Sigmoid Pharma Ltd Formulations
GB201319791D0 (en) 2013-11-08 2013-12-25 Sigmoid Pharma Ltd Formulations
EP3215127B1 (en) 2014-11-07 2020-10-28 Sublimity Therapeutics Limited Compositions comprising cyclosporin

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1051693A (es) * 1962-07-09
US3275622A (en) * 1963-12-18 1966-09-27 Syntex Corp 19-alkylidene-delta4-3, 20-keto pregnanes
US3275621A (en) * 1963-12-18 1966-09-27 Syntex Corp 19-amino-delta4-pregnenes and-10alpha-pregnenes and process for their preparation
US3558673A (en) * 1966-10-29 1971-01-26 Ormonoterapia Richter Spa 10beta-amino-19-nor-pregnanes and method for the preparation thereof
US3849402A (en) * 1971-01-06 1974-11-19 Steele Chem Co Ltd 19-oxygenated and 19-nor delta8(14)-steroid compounds
US4041055A (en) * 1975-11-17 1977-08-09 The Upjohn Company Process for the preparation of 17α-hydroxyprogesterones and corticoids from androstenes
FR2462445A1 (fr) * 1979-07-31 1981-02-13 Roussel Uclaf Nouveaux derives 17-/(hydroxymethyl) (formamido) methylene/steroides, leur procede de preparation et leur application a l'introduction de la chaine laterale hydroxyacetyle
US4289762A (en) * 1980-06-27 1981-09-15 Merrell Dow Pharmaceuticals Inc. 10-(1,2-Propadienyl) steroids as irreversible aromatase inhibitors
US4322416A (en) * 1980-06-27 1982-03-30 Merrell Dow Pharmaceuticals Inc. 10-Alkynyl steroids
US4293548A (en) * 1980-09-02 1981-10-06 Merrell Dow Pharmaceuticals Inc. 18-Substituted pregn-4-ene-3,20-diones
FR2498607A1 (fr) * 1981-01-29 1982-07-30 Roussel Uclaf Nouveau procede de preparation de 17a-hydroxy 17b-hydroxyacetyle steroides, produits intermediaires correspondants et produits finals obtenus
US4495102A (en) * 1982-09-03 1985-01-22 G. D. Searle & Co. Aminoalkyl steroids
US4473564A (en) * 1983-07-12 1984-09-25 Akzo N.V. 19-Thio-androstane derivatives
FR2576025B1 (fr) * 1985-01-14 1987-01-23 Roussel Uclaf Nouveaux steroides substitues en position 10, leur procede et les intermediaires de preparation, leur application comme medicaments, les compositions pharmaceutiques les contenant
GB8531745D0 (en) * 1985-12-24 1986-02-05 Erba Farmitalia 10beta-alkynyl-4-9(11)-estradiene derivatives

Also Published As

Publication number Publication date
KR910000588A (ko) 1991-01-29
PT90988B (pt) 1994-11-30
HUT51288A (en) 1990-04-28
IL90727A0 (en) 1990-01-18
CA1321578C (en) 1993-08-24
CN1033032C (zh) 1996-10-16
EP0348910B1 (en) 1995-05-17
FI893163A (fi) 1989-12-29
HU204066B (en) 1991-11-28
CN1039593A (zh) 1990-02-14
JPH0248598A (ja) 1990-02-19
IL90727A (en) 1993-05-13
JP2729320B2 (ja) 1998-03-18
FI92706C (fi) 1994-12-27
NZ229696A (en) 1992-03-26
US4910191A (en) 1990-03-20
DE68922660T2 (de) 1996-01-18
ATE122681T1 (de) 1995-06-15
PT90988A (pt) 1989-12-29
FI92706B (fi) 1994-09-15
AU3712789A (en) 1990-01-04
PH25714A (en) 1991-09-18
IE892086L (en) 1989-12-28
ES2075014T3 (es) 1995-10-01
NO892678D0 (no) 1989-06-27
EP0348910A2 (en) 1990-01-03
IE66338B1 (en) 1995-12-27
NO892678L (no) 1989-12-29
AU610473B2 (en) 1991-05-16
FI893163A0 (fi) 1989-06-28
NO174511C (es) 1994-05-18
DE68922660D1 (de) 1995-06-22
EP0348910A3 (en) 1990-03-21
NO174511B (no) 1994-02-07
DK167534B1 (da) 1993-11-15
KR0160280B1 (ko) 1998-11-16
DK318589D0 (da) 1989-06-27
DK318589A (da) 1989-12-29

Similar Documents

Publication Publication Date Title
IE840302L (en) 3-(5-aminopentyl)amino-1-benzazepin-2-one-1-alkanoic acids.
AU4840085A (en) Combinations of age inhibitors with dihydropyridines
EP0310072A3 (en) Non-peptidyl beta-succinamidoacyl aminodiols as anti-hypertensive agents
EP0350012A3 (en) Antiviral composition
EP0244803A3 (en) Novel dopamine beta hydroxylase inhibitors
PH25714A (en) 19-substituted progesterone derivatives useful as 19- HYDROXYLASE INHIBITORS
EP0313847A3 (en) Non-peptidyl alpha-succinamidoacyl aminodiols as anti-hypertensive agents
ES2002083A6 (es) Un metodo para preparar derivados de piroglutamida
NZ230711A (en) Substituted thienopyrans as antihypertensive agents
ZA894753B (en) 19-fluoro-or cyano-21-hydroxyprogesterone derivatives useful as 19-hydroxylase inhibitors
EP0297816A3 (en) Homocyclostatine and cyclostatine containing polypeptides as antihypertensive agents
AU3406189A (en) Agents for enhancing the growth of livestock